IM Cannabis Corp Regains Nasdaq Listing Compliance

IM Cannabis Corp regained compliance with the Nasdaq Stock Market's minimum bid price requirement of $1.00 per share. The company received a formal notice of compliance on September 22, 2026, after its ordinary shares closed at or above the threshold for 18 consecutive business days beginning August 27.

This development closes the bid price deficiency matter under Nasdaq Listing Rule 5550(a)(2). The company operates medical cannabis platforms in Israel and Germany.

As part of a broader strategic shift announced on August 17, 2026, the company intends to maintain its Israeli operations while selling its German operations. These German activities are conducted through its subsidiary, Adjupharm GmbH, and the sale is expected to occur upon the completion of pending transactions.